Stocks to Buy Aug 23, 2026 : Top Analyst Recommendations with Targets
Stocks to Buy Aug 23, 2026 : Top Analyst Recommendations with Targets
The Indian stock market is currently exhibiting moderate volatility amid fluctuating global cues and tightening domestic monetary policies. Sector rotation is gaining traction as investors selectively shift focus towards resilient industries like pharmaceuticals, banking, energy, and consumer discretionary. In such a dynamic environment, relying on analyst-backed stock selection is crucial to identify potential stocks to buy this week in India, ensuring strategic and well-informed investment decisions aligned with prevailing market trends.
Quick Snapshot
- Dabur India Limited (DABUR)
- State Bank of India (SBIN)
- Dr. Reddy’s Laboratories (DRREDDY)
- Pidilite Industries (PIDILITIND)
- NTPC Limited (NTPC)
Dabur India Limited (DABUR)
- Buy Range: Rs. 550 – Rs. 570
- Target Price: Rs. 630
- Stop Loss: Rs. 530
- Time Horizon: 3 to 5 months
Dabur India continues to demonstrate strong growth prospects driven by expanding rural demand and new product launches in the health supplements segment. Technically, the stock has formed a solid support base near Rs. 550 with increasing volume, indicating accumulation. The resilient consumer staples business and stable cash flow generation support a bullish outlook within a medium-term horizon.
Analyst Source: Kotak Securities
State Bank of India (SBIN)
- Buy-on-Dips Strategy: Rs. 570 – Rs. 590
- Target Price: Rs. 650
- Stop Loss: Rs. 550
- Time Horizon: 2 to 4 months
SBI remains a preferred banking stock due to its improving asset quality and robust loan growth. The recent consolidation presents attractive buying opportunities on dips as margins are expected to improve with easing credit costs. Analyst recommendations this week highlight SBI’s leadership in retail banking and digital initiatives as key growth drivers.
Analyst Source: HDFC Securities
Dr. Reddy’s Laboratories (DRREDDY)
- Buy Range: Rs. 4,300 – Rs. 4,400
- Target Price: Rs. 4,850
- Stop Loss: Rs. 4,150
- Time Horizon: 3 to 6 months
Dr. Reddy’s benefits from a diversified product pipeline and recent US FDA approvals boosting its export prospects. The stock is technically forming a base after recent corrections, offering potential upside on strength in the pharmaceutical sector and increasing margins from specialty drugs.
Analyst Source: ICICI Securities
Pidilite Industries (PIDILITIND)
- Buy-on-Dips Strategy: Rs. 2,450 – Rs. 2,480
- Target Price: Rs. 2,650
- Stop Loss: Rs. 2,350
- Time Horizon: 2 to 4 months
Pidilite continues to dominate the adhesives market with strong brand recognition and consistent margin expansion. Recent price corrections provide good entry points supported by robust demand in construction and consumer segments. Analysts emphasize the company’s pricing power and operational efficiency.
Analyst Source: Motilal Oswal Securities
NTPC Limited (NTPC)
- Buy Range: Rs. 215 – Rs. 220
- Target Price: Rs. 245
- Stop Loss: Rs. 205
- Time Horizon: 3 to 5 months
NTPC is well-positioned to benefit from increasing power demand and transition towards renewable energy projects. The stock’s technical setup shows a gradual strengthening with strong support near Rs. 215, while government policy support aids fundamentals.
Analyst Source: Edelweiss Securities
How to Use These Analyst Recommendations
These analyst recommendations this week are geared towards investors seeking stocks to buy this week in India with a reliable research foundation. It is important to use the suggested buy ranges and stop loss levels to manage potential downside risk. Investors should align these stocks to buy with their individual risk appetite and investment timelines. Monitoring these stocks regularly is advisable as market conditions evolve, ensuring optimal portfolio management.
Disclaimer
The stocks and price levels mentioned in this article are based on analyst recommendations from SEBI-registered brokerage firms and are provided for informational purposes only. This content does not constitute investment advice. Stock market investments are subject to market risks. Readers are advised to consult a SEBI-registered investment adviser before making any investment decisions.

